MFC Global
MFC Global is an Israeli privately held medical device company founded in 2013 that develops and sells the SpermVD, a CE-marked, FDA-registered vitrification device for cryopreserving small numbers of spermatozoa, serving IVF clinics, fertility laboratories, and embryologists worldwide through distributors and direct e-commerce.
- Company typePrivate
- Founded2013
- HeadquartersRishon Leziyyon, Israel
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What MFC Global does
MFC Global Ltd. is a privately held Israeli medical device company founded in 2013 by Pnina Berkovitz (CEO), Dr. Arie Berkovitz (CMO), and Dr. Pavel Itsykson (CTO), headquartered in Rishon LeZion with a secondary office in Givat Shmuel. The company develops and commercializes the SpermVD, an injection-molded polycarbonate medical device for vitrification-based cryopreservation of small numbers of spermatozoa — including single sperm cells — and the complementary SpermVD DISH Petri dish accessory. Both products are CE marked; the SpermVD is additionally FDA registered and ARTG registered. The underlying technology addresses severe male infertility cases (azoospermia, crypto-azoospermia, oligozoospermia) where traditional cryopreservation methods (mini-straws, ICSI pipette, cryoloop) have proven inadequate, with published clinical evidence of 96% post-warm retrieval and 55% clinical pregnancy rates.
MFC Global monetizes through two product SKUs sold in boxes of 25 units (SpermVD at $1,750 USD per box; SpermVD DISH at $390 USD per box) and through cryopreservation services delivered via its associated laboratory at Assuta Medical Center. Distribution is dual-track: direct e-commerce via the company website with PayPal processing for uncovered geographies, and a network of eleven authorized regional distributors spanning Europe (Denmark, Germany, Greece, Italy, Russia, Spain, Turkey), Asia (India, Vietnam), and the Americas (Brazil, Canada). Primary customers are IVF clinics, fertility laboratories, and embryologists; secondary end beneficiaries are male fertility patients facing cancer treatment, advancing age, or severe male-factor infertility.
The company is bootstrapped, with no disclosed institutional funding, M&A activity, or leadership turnover since founding. Growth is driven by scientific publication, peer-reviewed clinical validation, multi-jurisdiction regulatory clearance, and incremental geographic expansion through distributor partnerships rather than capital-intensive sales scaling. Key opinion leader credibility is anchored by co-founder Dr. Arie Berkovitz, inventor of the IMSI method, and by Dr. Pavel Itsykson's ongoing role as IVF laboratory director at Assuta Medical Center.
MFC Global firmographics
Firmographics- Name
- MFC Global
- Legal name
- MFC Global Ltd.
- Website
- https://mfc-global.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MFC Global is an Israeli privately held medical device company founded in 2013 that develops and sells the SpermVD, a CE-marked, FDA-registered vitrification device for cryopreserving small numbers of spermatozoa, serving IVF clinics, fertility laboratories, and embryologists worldwide through distributors and direct e-commerce.
- Ownership category
- akta.pro rank
Where MFC Global is headquartered
LocationHeadquarters
- HQ city
- Rishon Leziyyon
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
MFC Global business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- SpermVD Device Sales: Sale of SpermVD cryopreservation devices - sterile, disposable single-use devices sold in boxes of 25 units. Revenue generated from direct online sales and through distributor network globally.
- SpermVD DISH Accessory Sales: Sale of SpermVD DISH accessories - complementary products designed to enhance and optimize the freezing and warming process. Sold in boxes of 25 units.
- Cryopreservation Services: The company operates an associated laboratory that provides IVF and cryopreservation services to customers in Israel and abroad.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | SpermVD - Box of 25 units |
| Unit Pricing | Pay-as-you-go | SpermVD DISH - Box of 25 units |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
MFC Global product offering
Product offeringCore offering
MFC Global designs, manufactures and sells the SpermVD, a proprietary CE-marked, FDA-registered medical device for vitrification-based cryopreservation of small numbers of spermatozoa (single cell to thousands). The company also offers the SpermVD DISH accessory Petri dish optimized for SpermVD workflows, and operates an associated laboratory providing sperm cryopreservation services to IVF clinics in Israel and abroad.
Product overview
MFC Global offers a focused product portfolio centered on the SpermVD, an innovative medical device for vitrification-based cryopreservation of small numbers of spermatozoa. The core SpermVD product works in conjunction with the SpermVD DISH accessory, which provides a purpose-designed dish to enhance handling and processing. The company also provides related cryopreservation services through its associated laboratory. All products are designed for use in IVF clinics and laboratories treating male infertility cases including azoospermia, cryptoazoospermia, and oligoazoospermia.
Differentiator
Problem solved
Functional benefit
Brands
- SpermVD: Innovative medical device for cryopreservation of small numbers of spermatozoa, enabling vitrification from a single cell to thousands. CE marked, FDA and ARTG registered.
- SpermVD DISH
Products and services
- SpermVD
Quantifiable outcome
- 96% post-warm retrieval rate of frozen spermatozoa
- +5 more outcomes
Companies that use MFC Global
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles1 record
MFC Global technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
MFC Global partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered regional and core.
- Nordic Cell ApSregionalAuthorized distributor for Denmark. Markets and sells MFC Global products including SpermVD and SpermVD DISH to fertility clinics in the Nordic region.
- Gynemed GmbH & Co. KGregionalAuthorized distributor for Germany. Markets and sells MFC Global products to fertility clinics and laboratories.
- MEDIPLAN LtdregionalAuthorized distributor for Greece. Markets and sells MFC Global products to fertility clinics in Greece.
- SOL SPAregionalAuthorized distributor for Italy. Markets and sells MFC Global products to fertility clinics and laboratories in Italy.
- BMT Ltd.regionalAuthorized distributor for Russian Federation. Markets and sells MFC Global products to fertility clinics in Russia.
- CIMAB IBERICA S.L.regionalAuthorized distributor for Spain. Markets and sells MFC Global products to fertility clinics and laboratories in Spain.
- Bil-TekregionalAuthorized distributor for Turkey. Markets and sells MFC Global products to fertility clinics in Turkey.
- SpectrunregionalAuthorized distributor for Brazil. Markets and sells MFC Global products to fertility clinics in Brazil.
- IntermedicsregionalAuthorized distributor for India. Markets and sells MFC Global products to fertility clinics and laboratories in India.
- TOAN ANH CO Ltd.regionalAuthorized distributor for Vietnam. Markets and sells MFC Global products to fertility clinics and medical facilities in Vietnam.
- Fertitech CanadaregionalAuthorized distributor for Canada. Markets and sells MFC Global products to fertility clinics and laboratories in Canada.
- Assuta Medical CentercoreThe company operates its associated laboratory at Assuta Medical Center in Rishon Le-zion, Israel. Dr. Pavel Itsykson serves as IVF laboratory Director at Assuta. Products are tested and used routinely in this clinical setting.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
MFC Global competitors and assessment
Company assessmentBroad incumbents
- Vitrolife: Vitrolife is a global leader in IVF media, consumables, and devices serving embryologists and fertility clinics. With its established product portfolio, global sales coverage, and clinical evidence base, it competes with MFC Global across the broader ART consumables space where the SpermVD is positioned.
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a broad ART media and consumables supplier offering culture media, vitrification solutions, and devices across the IVF workflow. As a large established player with global distribution, it competes with MFC Global on adjacent cryopreservation products and has the scale to bundle or replicate sperm vitrification solutions.
- Hamilton Thorne: Hamilton Thorne supplies laser systems, micromanipulators, and related ART devices used in ICSI and cryopreservation workflows. As a supplier to embryologists globally, it competes in adjacent parts of the same clinical process where SpermVD is employed.
- CooperSurgical (Wallace / ORIGIO / Research Instruments): CooperSurgical's fertility portfolio includes Wallace, ORIGIO, and Research Instruments lines covering ART devices, micromanipulators, and consumables. It is a broad incumbent with overlapping sperm handling, ICSI, and vitrification products sold to the same fertility clinic audience.
Emerging players
- Midatlantic Diagnostics / Cryobio (MTG Medical): MTG Medical / Cryobio supplies cryopreservation devices and tools for sperm, oocytes, and embryos across fertility clinics. It is comparable to MFC Global as a focused ART cryopreservation consumables specialist.
- Bio-Techne (formerly Trophos / Vitromed): Bio-Techne supplies ART media and consumables used in IVF workflows including cryopreservation. Its portfolio overlap with MFC Global centers on consumables used by embryologists to handle and preserve gametes.
Direct peers
- Kitazato Corporation: Kitazato is a Japanese ART consumables company best known for its Cryotop vitrification device for oocytes and embryos, and also supplies cryopreservation tools for sperm. It is the most direct competitor to MFC Global in the vitrification consumables category, addressing the same IVF clinic and embryologist customer base.
- Genea Biomedx: Genea Biomedx develops and sells ART devices and consumables, including vitrification and culture tools, targeting the same embryologist and IVF lab customer base. Its range of cryopreservation and micromanipulation products directly overlaps with the workflow where the SpermVD is used.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MFC Global social profiles
Digital presenceMFC Global compliance and trust
Trust signalCompliance3 records
MFC Global financial estimates
Financial estimateRevenue estimate
Valuation estimate
MFC Global leadership team
Management profileNumber of profiles
Profiles3 records
MFC Global funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MFC Global M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MFC Global
What does MFC Global do?
MFC Global designs, manufactures and sells the SpermVD, a proprietary CE-marked, FDA-registered medical device for vitrification-based cryopreservation of small numbers of spermatozoa (single cell to thousands). The company also offers the SpermVD DISH accessory Petri dish optimized for SpermVD workflows, and operates an associated laboratory providing sperm cryopreservation services to IVF clinics in Israel and abroad.
Is MFC Global a public or private company?
MFC Global is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MFC Global founded?
MFC Global was founded in 2013. It employs 1 to 10 people.
Where is MFC Global based?
MFC Global is headquartered in Rishon Leziyyon, Israel, in the Middle East region.
How does MFC Global make money?
Three revenue lines are on record. SpermVD Device Sales are the primary driver. The others are spermVD DISH Accessory Sales and cryopreservation Services.
Who are MFC Global's main competitors?
Broad incumbents on record are Vitrolife, FUJIFILM Irvine Scientific, Hamilton Thorne and CooperSurgical (Wallace / ORIGIO / Research Instruments). Emerging players are Midatlantic Diagnostics / Cryobio (MTG Medical) and Bio-Techne (formerly Trophos / Vitromed). Direct peers are Kitazato Corporation and Genea Biomedx.
Does MFC Global have an API?
No public API is recorded for MFC Global.